Vyvanse and Paranoia - from FDA reports
Paranoia is found among people who take Vyvanse, especially for people who are male, 2-9 old , have been taking the drug for < 1 month, also take medication Seroquel, and have Malaria. This review analyzes which people have Paranoia with Vyvanse. It is created by eHealthMe based on reports of 12,038 people who have side effects when taking Vyvanse from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 21, 2017
12,038 people reported to have side effects when taking Vyvanse.
Among them, 120 people (1.0%) have Paranoia
Number of reports submitted per year:
Time on Vyvanse when people have Paranoia *:
- < 1 month: 50.0 %
- 1 - 6 months: 16.67 %
- 6 - 12 months: 22.22 %
- 1 - 2 years: 5.56 %
- 2 - 5 years: 5.56 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Paranoia when taking Vyvanse *:
- female: 44.07 %
- male: 55.93 %
Age of people who have Paranoia when taking Vyvanse *:
- 0-1: 1.06 %
- 2-9: 30.85 %
- 10-19: 28.72 %
- 20-29: 13.83 %
- 30-39: 9.57 %
- 40-49: 13.83 %
- 50-59: 2.13 %
- 60+: 0.0 %
Top conditions involved for these people *:
- Sleep Disorder (4 people, 3.33%)
- Multiple Allergies (4 people, 3.33%)
- Malaria (4 people, 3.33%)
- Hypersensitivity (3 people, 2.50%)
- Aggression (3 people, 2.50%)
Top co-used drugs for these people *:
- Seroquel (7 people, 5.83%)
- Strattera (6 people, 5.00%)
- Risperdal (6 people, 5.00%)
- Lexapro (6 people, 5.00%)
- Celexa (6 people, 5.00%)
Top other side effects for these people *:
- Insomnia (25 people, 20.83%)
- Hallucinations (22 people, 18.33%)
- Agitation (17 people, 14.17%)
- Aggression (17 people, 14.17%)
- Appetite - Decreased (16 people, 13.33%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Paranoia when taking Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 15,871 users)
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur) has been reported by people with pain, depression, quit smoking, attention deficit hyperactivity disorder, stress and anxiety (latest reports from 14,989 Paranoia patients).